Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Treatment in Aggrecan Deficiency
NCT03288103Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Feb 2018
- Primary completion
- Mar 2023
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in Aggrecan Deficiency, sponsored by Cincinnati Children's Hospital Medical Center. Started Feb 2018; status: completed.
02
Drugs
somatropin
03
Conditions
Aggrecan Deficiency
Beyond the preview
Go deeper on NCT03288103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288103.